News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,119 Results
Type
Article (43867)
Company Profile (284)
Press Release (684968)
Section
Business (213055)
Career Advice (2179)
Deals (36858)
Drug Delivery (107)
Drug Development (83341)
Employer Resources (176)
FDA (17042)
Job Trends (15543)
News (360037)
Policy (34502)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2666)
Accelerated approval (5)
Adcomms (23)
Allergies (85)
Alliances (52198)
ALS (87)
Alzheimer's disease (1382)
Antibody-drug conjugate (ADC) (117)
Approvals (17041)
Artificial intelligence (251)
Autoimmune disease (17)
Automation (14)
Bankruptcy (371)
Best Places to Work (12016)
BIOSECURE Act (18)
Biosimilars (108)
Biotechnology (189)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (258)
Cancer (2069)
Cardiovascular disease (169)
Career advice (1822)
Career pathing (29)
CAR-T (153)
Cell therapy (424)
Cervical cancer (19)
Clinical research (67506)
Collaboration (797)
Compensation (467)
Complete response letters (21)
COVID-19 (2691)
CRISPR (40)
C-suite (219)
Cystic fibrosis (101)
Data (2010)
Decentralized trials (2)
Denatured (26)
Depression (41)
Diabetes (265)
Diagnostics (6570)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (114)
Drug pricing (104)
Drug shortages (29)
Duchenne muscular dystrophy (88)
Earnings (89151)
Editorial (34)
Employer branding (21)
Employer resources (150)
Events (116730)
Executive appointments (670)
FDA (18204)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (713)
Gene editing (103)
Generative AI (19)
Gene therapy (298)
GLP-1 (742)
Government (4602)
Grass and pollen (5)
Guidances (49)
Healthcare (19516)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (107)
Indications (27)
Infectious disease (2828)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (89)
Interviews (337)
IPO (16970)
IRA (43)
Job creations (3971)
Job search strategy (1553)
Kidney cancer (9)
Labor market (34)
Layoffs (483)
Leadership (16)
Legal (8399)
Liver cancer (74)
Lung cancer (299)
Lymphoma (136)
Machine learning (4)
Management (61)
Manufacturing (290)
MASH (61)
Medical device (14179)
Medtech (14184)
Mergers & acquisitions (20376)
Metabolic disorders (669)
Multiple sclerosis (73)
NASH (16)
Neurodegenerative disease (87)
Neuropsychiatric disorders (24)
Neuroscience (1885)
NextGen: Class of 2025 (6809)
Non-profit (4576)
Northern California (2495)
Now hiring (37)
Obesity (360)
Opinion (230)
Ovarian cancer (72)
Pain (85)
Pancreatic cancer (77)
Parkinson's disease (141)
Partnered (20)
Patents (211)
Patient recruitment (99)
Peanut (49)
People (59396)
Pharmaceutical (78)
Pharmacy benefit managers (18)
Phase I (21065)
Phase II (29679)
Phase III (22171)
Pipeline (1071)
Podcasts (60)
Policy (117)
Postmarket research (2640)
Preclinical (8897)
Press Release (71)
Prostate cancer (97)
Psychedelics (31)
Radiopharmaceuticals (256)
Rare diseases (369)
Real estate (6331)
Recruiting (66)
Regulatory (23547)
Reports (46)
Research institute (2407)
Resumes & cover letters (367)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (67)
Series A (124)
Series B (82)
Service/supplier (14)
Sickle cell disease (53)
Southern California (2147)
Special edition (15)
Spinal muscular atrophy (153)
Sponsored (32)
Startups (3804)
State (2)
Stomach cancer (13)
Supply chain (63)
Tariffs (11)
The Weekly (32)
United States (21864)
Vaccines (703)
Venture capitalists (38)
Webinars (13)
Weight loss (247)
Women's health (35)
Worklife (16)
Date
Today (56)
Last 7 days (672)
Last 30 days (2657)
Last 365 days (34311)
2025 (8521)
2024 (36230)
2023 (41204)
2022 (52474)
2021 (57191)
2020 (55783)
2019 (48575)
2018 (36640)
2017 (33857)
2016 (33443)
2015 (39499)
2014 (33079)
2013 (28253)
2012 (30499)
2011 (31057)
2010 (28926)
Location
Africa (784)
Alabama (49)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (40990)
Australia (6757)
California (5677)
Canada (1901)
China (489)
Colorado (253)
Connecticut (266)
Delaware (133)
Europe (89550)
Florida (832)
Georgia (199)
Hawaii (1)
Idaho (60)
Illinois (530)
India (25)
Indiana (304)
Iowa (9)
Japan (145)
Kansas (105)
Kentucky (25)
Louisiana (10)
Maine (69)
Maryland (862)
Massachusetts (4284)
Michigan (229)
Minnesota (384)
Mississippi (2)
Missouri (84)
Montana (29)
Nebraska (25)
Nevada (56)
New Hampshire (66)
New Jersey (1633)
New Mexico (29)
New York (1622)
North Carolina (981)
North Dakota (8)
Northern California (2495)
Ohio (196)
Oklahoma (14)
Oregon (38)
Pennsylvania (1278)
Puerto Rico (9)
Rhode Island (28)
South America (1196)
South Carolina (18)
South Dakota (1)
Southern California (2147)
Tennessee (95)
Texas (852)
Utah (170)
Virginia (140)
Washington D.C. (59)
Washington State (531)
West Virginia (3)
Wisconsin (51)
729,119 Results for "aspen surgical products inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aspen Medical Products Acquires Advanced Orthopaedics
January 30, 2025
·
2 min read
Press Releases
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson’s Disease
January 8, 2025
·
3 min read
Biotech Beach
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
ClearPoint Neuro, Inc. congratulates its partner Aspen Neuroscience, Inc. on use of the ClearPoint Neuro Navigation System to transplant dopaminergic neuron precursor cells for all enrolled patients with Parkinson’s Disease in its recently launched ASPIRO Phase 1/2a clinical trial.
June 20, 2024
·
6 min read
Deals
Aspen Surgical Acquires Symmetry Surgical
Aspen Surgical Products, Inc. (“Aspen”), a portfolio company of Audax Private Equity (“Audax”) and a leader in disposable surgical products, announced the acquisition of Symmetry Surgical (“Symmetry”) from RoundTable Healthcare Partners. Symmetry represents Aspen’s 15th acquisition in total and sixth since Audax’ initial investment in Aspen in 2019.
October 27, 2022
·
5 min read
Press Releases
Aspen Medical Products Launches First Bracing Solution Available for PJK Mitigation
August 7, 2024
·
4 min read
Press Releases
Aspen Neuroscience Announces Completion of First and Second Cohorts in ASPIRO Phase 1/2a Trial for Parkinson’s Disease
January 13, 2025
·
3 min read
Biotech Beach
Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)
Aspen Neuroscience, Inc. has received a CLIN2 grant award of $8 million from the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, to support clinical research aimed at treating Parkinson’s disease (PD).
May 15, 2024
·
4 min read
Business
Aspen Neuroscience Appoints Ana Sousa Chief Regulatory Officer
Aspen Neuroscience, Inc. announced the appointment of Ana Sousa, MSJ as the company’s Chief Regulatory Officer.
January 16, 2024
·
2 min read
Pharm Country
Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced positive topline results from the ASPEN study, a global, randomized, double-blind, placebo-controlled Phase 3 study to assess the efficacy, safety, and tolerability of brensocatib in patients with non-cystic fibrosis bronchiectasis.
May 28, 2024
·
13 min read
Biotech Beach
Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting
Aspen Neuroscience will present this week to a global audience of clinicians, regulators, researchers, technologists and industry partners at the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, May 29-June 1.
May 30, 2024
·
3 min read
1 of 72,912
Next